Nomura analyst Jeffrey Kvaal believes Infinera Corp. INFN offered a health structural sales growth. The analyst also expects the company's margin expansion story to help its bottom line in the upcoming years. As a result, the analyst initiated the stock with a rating of Buy with a price target of $17. It meant the stock provided 28.2 percent upside rewards based on Thursday's closing price.
The brokerage said Infinera's PIC chip has driven share gains in a growing optical market. This included the rapidly expanding webscale customers. Kvaal also expects emerging webscale competition and weakness as a key customer mar the current year's story.
However, the analyst commented, "we believe INFN's 1Q reset has de-risked estimates, providing an attractive multiple for an entry point." Accordingly, the revised fiscal year 2016 EPS estimation is $0.85 and for the fiscal year 2017, the analyst project $0.91.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.